Detection of hepatitis C virus subtypes 6a, 6n, 6w and mixed infections using a modified multiplex real-time polymerase chain reaction protocol

Yuan Ming Lee, Yen Ju Chen, Cheng Ming Lee, Lou Hui Kuo, Wing Wai Wong, Yi Ming Arthur Chen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Purpose: In the past few years, many new subtypes in hepatitis C virus (HCV) genotype 6 have been identified. The aim of this study was to modify the multiplex real-time polymerase chain reaction (RT-PCR) protocol and use it to determine the HCV subtypes of a group of Taiwanese injection drug users (IDUs). Methods: We used 76 serum specimens collected in northern Taiwan in 2008. Multiplex RT-PCR was used for HCV subtyping among those serum samples having anti-HCV antibodies. Twenty cases were randomly selected for comparison with subtyping results from Inno-LiPa II tests and phylogenetic tree analysis using NS5B sequences. Results: Multiplex RT-PCR assays showed that 60.5% (46/76) of IDUs had single HCV infection. Three out of 76 (3.9%) had double HCV infection (1b/6a, 2a/2b and 2b/6a). Besides this, 27.6% (21/76) had no HCV signal. One IDU had subtype 6n and two had subtype 6w infection. Inno-LiPa II tests misclassified all 6n and 6w cases as 1b subtype. Conclusion: Our modified multiplex RT-PCR protocol can be used to support molecular epidemiological studies and laboratory diagnoses of different HCV subtypes including genotype 6.

Original languageEnglish
Pages (from-to)762-767
Number of pages6
JournalJournal of the Formosan Medical Association
Volume110
Issue number12
DOIs
Publication statusPublished - Dec 1 2011
Externally publishedYes

Fingerprint

Multiplex Polymerase Chain Reaction
Coinfection
Hepacivirus
Real-Time Polymerase Chain Reaction
Drug Users
Virus Diseases
Injections
Genotype
Hepatitis C Antibodies
Clinical Laboratory Techniques
Serum
Taiwan
Epidemiologic Studies
Infection

Keywords

  • Genotype 6
  • Hepatitis C virus (HCV)
  • Injection drug users
  • Inno-LiPa II test
  • Multiplex RT-PCR
  • Subtype 6n
  • Subtype 6w

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Detection of hepatitis C virus subtypes 6a, 6n, 6w and mixed infections using a modified multiplex real-time polymerase chain reaction protocol. / Lee, Yuan Ming; Chen, Yen Ju; Lee, Cheng Ming; Kuo, Lou Hui; Wong, Wing Wai; Arthur Chen, Yi Ming.

In: Journal of the Formosan Medical Association, Vol. 110, No. 12, 01.12.2011, p. 762-767.

Research output: Contribution to journalArticle

@article{68f3ebc014604f1694f324603e9e82d6,
title = "Detection of hepatitis C virus subtypes 6a, 6n, 6w and mixed infections using a modified multiplex real-time polymerase chain reaction protocol",
abstract = "Background/Purpose: In the past few years, many new subtypes in hepatitis C virus (HCV) genotype 6 have been identified. The aim of this study was to modify the multiplex real-time polymerase chain reaction (RT-PCR) protocol and use it to determine the HCV subtypes of a group of Taiwanese injection drug users (IDUs). Methods: We used 76 serum specimens collected in northern Taiwan in 2008. Multiplex RT-PCR was used for HCV subtyping among those serum samples having anti-HCV antibodies. Twenty cases were randomly selected for comparison with subtyping results from Inno-LiPa II tests and phylogenetic tree analysis using NS5B sequences. Results: Multiplex RT-PCR assays showed that 60.5{\%} (46/76) of IDUs had single HCV infection. Three out of 76 (3.9{\%}) had double HCV infection (1b/6a, 2a/2b and 2b/6a). Besides this, 27.6{\%} (21/76) had no HCV signal. One IDU had subtype 6n and two had subtype 6w infection. Inno-LiPa II tests misclassified all 6n and 6w cases as 1b subtype. Conclusion: Our modified multiplex RT-PCR protocol can be used to support molecular epidemiological studies and laboratory diagnoses of different HCV subtypes including genotype 6.",
keywords = "Genotype 6, Hepatitis C virus (HCV), Injection drug users, Inno-LiPa II test, Multiplex RT-PCR, Subtype 6n, Subtype 6w",
author = "Lee, {Yuan Ming} and Chen, {Yen Ju} and Lee, {Cheng Ming} and Kuo, {Lou Hui} and Wong, {Wing Wai} and {Arthur Chen}, {Yi Ming}",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.jfma.2011.11.006",
language = "English",
volume = "110",
pages = "762--767",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "12",

}

TY - JOUR

T1 - Detection of hepatitis C virus subtypes 6a, 6n, 6w and mixed infections using a modified multiplex real-time polymerase chain reaction protocol

AU - Lee, Yuan Ming

AU - Chen, Yen Ju

AU - Lee, Cheng Ming

AU - Kuo, Lou Hui

AU - Wong, Wing Wai

AU - Arthur Chen, Yi Ming

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Background/Purpose: In the past few years, many new subtypes in hepatitis C virus (HCV) genotype 6 have been identified. The aim of this study was to modify the multiplex real-time polymerase chain reaction (RT-PCR) protocol and use it to determine the HCV subtypes of a group of Taiwanese injection drug users (IDUs). Methods: We used 76 serum specimens collected in northern Taiwan in 2008. Multiplex RT-PCR was used for HCV subtyping among those serum samples having anti-HCV antibodies. Twenty cases were randomly selected for comparison with subtyping results from Inno-LiPa II tests and phylogenetic tree analysis using NS5B sequences. Results: Multiplex RT-PCR assays showed that 60.5% (46/76) of IDUs had single HCV infection. Three out of 76 (3.9%) had double HCV infection (1b/6a, 2a/2b and 2b/6a). Besides this, 27.6% (21/76) had no HCV signal. One IDU had subtype 6n and two had subtype 6w infection. Inno-LiPa II tests misclassified all 6n and 6w cases as 1b subtype. Conclusion: Our modified multiplex RT-PCR protocol can be used to support molecular epidemiological studies and laboratory diagnoses of different HCV subtypes including genotype 6.

AB - Background/Purpose: In the past few years, many new subtypes in hepatitis C virus (HCV) genotype 6 have been identified. The aim of this study was to modify the multiplex real-time polymerase chain reaction (RT-PCR) protocol and use it to determine the HCV subtypes of a group of Taiwanese injection drug users (IDUs). Methods: We used 76 serum specimens collected in northern Taiwan in 2008. Multiplex RT-PCR was used for HCV subtyping among those serum samples having anti-HCV antibodies. Twenty cases were randomly selected for comparison with subtyping results from Inno-LiPa II tests and phylogenetic tree analysis using NS5B sequences. Results: Multiplex RT-PCR assays showed that 60.5% (46/76) of IDUs had single HCV infection. Three out of 76 (3.9%) had double HCV infection (1b/6a, 2a/2b and 2b/6a). Besides this, 27.6% (21/76) had no HCV signal. One IDU had subtype 6n and two had subtype 6w infection. Inno-LiPa II tests misclassified all 6n and 6w cases as 1b subtype. Conclusion: Our modified multiplex RT-PCR protocol can be used to support molecular epidemiological studies and laboratory diagnoses of different HCV subtypes including genotype 6.

KW - Genotype 6

KW - Hepatitis C virus (HCV)

KW - Injection drug users

KW - Inno-LiPa II test

KW - Multiplex RT-PCR

KW - Subtype 6n

KW - Subtype 6w

UR - http://www.scopus.com/inward/record.url?scp=84855830452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855830452&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2011.11.006

DO - 10.1016/j.jfma.2011.11.006

M3 - Article

C2 - 22248830

AN - SCOPUS:84855830452

VL - 110

SP - 762

EP - 767

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 12

ER -